The Antibody Shared Resource (ASR) is a dedicated high-throughput facility for antibody generation and related technologies. At the time of the last competitive renewal, this shared resource received an """"""""Outstanding"""""""" rating. A major role for the ASR is to generate monoclonal (mAb) and polyclonal (pAb) antibodies and to make a broad range of antibody-related technologies cost effective and readily available to VICC investigators. For both mAb and pAb projects, the ASR offers end-to-end service that includes (1) antigen design, expression, and purification, (2) immunization and bleeding, and (3) protein-G (monoclonal) or antigen (polyclonal) affinity purification. Thus, investigators with no experience in the generation of antibodies can quickly and efficiently move a project forward. For monoclonal projects, ASR staff work closely with VICC investigators to ensure that the antibody screens are designed to capture antibodies tailored to their specific needs (e.g., immunoprecipitation, immunohistochemistry, receptor neutralization, etc). For polyclonal antibodies, aside from an initial consult, the ASR will handle the entire project, returning high quality affinity purified antibody. In addition, ASR staff provide a wide range of antibody support services including hybridoma subcloning, isotyping, ELISA screening, antibody scale up and large-scale production, antibody labeling (e.g., fluorophores, biotin, quantum dots, etc.), conjugation to affinity matrices (e.g., magnetic proteomic beads, sepharose), long-term hybridoma storage, and protein (antigen) design, expression, and purification. All shared resource services are offered at cost with rapid turnaround. Albert Reynolds, Ph.D., Professor of Cancer Biology with more than 20 years'experience with monoclonal antibody technology, directs this Resource as Scientific Director. Dr. Robert Carnahan, Research Assistant Professor of Cancer Biology, is the ASR Managing Director and oversees all aspects of daily operation. The staff is comprised of four technicians with specialized training in the full spectrum of services and methodologies provides by this resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733537
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$178,605
Indirect Cost
$89,303
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Piñeros, Marion; Frech, Silvina; Frazier, Lindsay et al. (2018) Advancing Reliable Data for Cancer Control in the Central America Four Region. J Glob Oncol :1-11

Showing the most recent 10 out of 2462 publications